Who is sponsoring NCT03590236?

NCT03590236 is sponsored by Universidad de Granada.

What drugs are being tested in NCT03590236?

Interventions in NCT03590236: Graded exposure therapy, Physiotherapy.

What condition does NCT03590236 study?

NCT03590236 studies Chronic Pelvic Pain.

Is NCT03590236 still recruiting?

NCT03590236 is currently status unknown. Last updated 18 July 2018.

Last reviewed 2018-07-18 · How we verify

NCT03590236

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Graded Exposure Therapy in Chronic Pelvic Pain

Status unknown NA Last updated 18 July 2018

What this trial tests

NA trial testing Graded exposure therapy in Chronic Pelvic Pain in 60 participants. Status unknown.

Timeline

20 August 2017

Primary endpoint
12 February 2018

10 August 2018

Quick facts

Lead sponsor	Universidad de Granada
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	60
Start date	20 August 2017
Primary completion	12 February 2018
Estimated completion	10 August 2018
Sites	1 location across Spain

Drugs / interventions tested

Graded exposure therapy
Physiotherapy — full drug profile →

Conditions studied

Chronic Pelvic Pain — all drugs for Chronic Pelvic Pain →

Sponsor

Universidad de Granada — full company profile →

Who can join

Adults 18 to 65, female only, with Chronic Pelvic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic pelvic pain (CPP) is considered as nonmalignant recurrent or continuous pain related to the structures of the pelvis. The objective of this study was to evaluate the effects of graded exposure therapy in women with chronic pelvic pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Treatments for kinesiophobia in people with chronic pain: A scoping review.
Bordeleau M, Vincenot M, Lefevre S, Duport A, et al · · 2022 · cited 61× · PMID 36204486 · DOI 10.3389/fnbeh.2022.933483

Verify or expand the search:

Other trials of Graded exposure therapy

Trials testing the same drug.

NCT03972579 — Behavioral Profile Matching: A Precision Medicine Approach to Concussion Rehabilitation · NA · completed

Other recruiting trials for Chronic Pelvic Pain

Currently open trials in the same condition.

NCT06995287 — Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysme · Phase 3 · recruiting
NCT06778070 — National Program to Overcome Pelvic Pain studY (POPPY) · NA · recruiting
NCT06413277 — Targeting the Conus Medullaris With ECAP-Controlled Closed-Loop SCS for Treatment of Chronic Pelvic Pain: HOPE Trial · recruiting
NCT07494864 — Effects of Microbiological and Immunological Factors on the Lower Urinary Tract · recruiting
NCT06908200 — Effect of Radiofrequency in Women With Chronic Pelvic Pain With an Associated Myofascial Syndrome Versus Myofascial Ther · NA · recruiting

Other Universidad de Granada trials

Trials by the same sponsor.

NCT07497698 — Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults · NA · recruiting
NCT07528924 — TuJugling: Comparing Two Juggling Learning Methods in College Students · NA · recruiting
NCT07388134 — Virtual Reality Based High-intensity Interval Training in Chronic Low Back Pain · NA · active not recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT06518200 — Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03590236 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Granada
Last refreshed: 18 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03590236.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing